The Source • December 2006 • Issue 94

Comments from AI Survey Respondents

I felt like I was 80 years old. Stopped AI after six months. —Woman in her 40s ………………………………………………………………………………………………… I cannot emphasize enough the side effect of pain and fatigue that I experienced while on AIs…the joint pain is impossible…I know these side effects are from… Read More

From the Executive Director: Meeting the Needs of Patients: BCA’s Survey on Aromatase Inhibitors

by Barbara A. Brenner I was at the San Antonio Breast Cancer Symposium in 2001 when the first results of a trial looking at an aromatase inhibitor (AI)—the ATAC trial (Arimidex, Tamoxifen Alone or in Combination)—were presented. I knew from the buzz at the meeting… Read More

Spotlight: Marilyn Zivian—Finding the Stories in the Data

by Rebecca Farmer First diagnosed with breast cancer in 1986 when she was 47, Marilyn Zivian has been living with metastatic disease for ten years, after a recurrence in 1996. A trained researcher and former university professor, she’s also the lead author of the new… Read More